Estimating cell death in G2M using bivariate BrdUrd/DNA flow cytometry

Cytometry Part A

Volumn 66, Issue 1, 2005, Pages 32-40

  White, R Allen ^a   Asmuth, David M ^c   Lu, Ying ^c   Wang, Nan ^b   Li, Xiao Dong ^c   Reece, Lisa ^b   Pollard, Richard B ^c   Nokta, Mostafa ^b   Leary, James F ^b   Terry, Nicholas H A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bromodeoxyuridine; Cell cycle; Phase durations; Population growth

Indexed keywords

ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL FRACTIONATION; CELL LABELING; DNA CONTENT; FLOW CYTOMETRY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ANIMALS; BROMODEOXYURIDINE; CELL DEATH; CELL PROLIFERATION; CELL SEPARATION; DNA; FLOW CYTOMETRY; G2 PHASE; HUMANS; MITOSIS; MODELS, BIOLOGICAL; PROBABILITY;

EID: 20944436936     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.20147     Document Type: Article

References (37)

1. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 1983;80:5573-5577.
2. Dolbeare F, Beisker W, Pallavicini MG, Vanderlaan M, Gray JW. Cytochemistry for broraodeoxyuridine/DNA analysis: stoichiometry and sensitivity. Cytometry 1985;6:521-530.
3. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine, part I: historical perspectives, histochemical methods and cell kinetics. Histochem J 1995;27:339-369.
4. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine, part II: oncology, chemotherapy and carcinogenesis. Histochem J 1995;27:923-964.
5. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine, part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization. Histochem J 1996;28:531-575.
6. Terry NH, White RA. Cell cycle kinetics estimated by analysis of bromodeoxyuridine incorporation. Methods Cell Biol 2001;63:355-374.
7. Begg AC, McNally NJ, Shrieve DC, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985;6:620-626.
8. Carlton JC, Terry NH, White RA. Measuring potential doubling times of murine tumors using flow cytometry. Cytometry 1991;12:645-650.
9. Durand RE. Determining Tpot in heterogeneous systems: a new approach illustrated with multicell spheroids. Cytometry 1993;14: 527-534.
10. Johansson MC, Johansson R, Baldetorp B, Oredsson SM. Comparison of different labelling index formulae used on bromodeoxyuridine-flow cytometry data. Cytometry 1998;32:233-240.
11. Keng PC, Siemann DW. Measurement of proliferation activities in human tumor models: a comparison of flow cytometric methods. Radiat Oncol Investig 1998;6:120-127.
12. Pollack A, White RA, Cao S, Meistrich ML, Terry NH. Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues. Int J Radiat Oncol Biol Phys 1993; 27:1131-1139.
13. Ritter MA, Fowler JF, Kim YJ, Gilchrist KW, Morrissey LW, Kinsella TJ. Tumor cell kinetics using two labels and flow cytometry. Cytometry 1994;16:49-58.
14. Ritter MA, Fowler JF, Kim Y, Lindstrom MJ, Kinsella TJ. Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals. Int J Radiat Oncol Biol Phys 1992;23:811-820.
15. Terry NH, White RA, Meistrich ML, Calkins DP. Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells. Cytometry 1991;12:234-241.
16. Torricelli A, Bisiach M, Spinelli L, Ubezio P. From flow cytometric BrdUrd data to cell population growth and doubling time. Cytometry 1997;29:222-232.
17. White RA, Meistrich ML, Pollack A, Terry NH. Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry. Cytometry 2000;41:1-8.
18. White RA, Terry NH, Baggerly KA, Meistrich ML. Measuring cell proliferation by relative movement. I. Introduction and in vitro studies. Cell Prolif 1991;24:257-270.
19. White RA, Meistrich ML. A comment on "A method to measure the duration of DNA synthesis and the potential doubling time from a single sample." Cytometry 1986;7:486-490.
20. White RA. A theory for analysis of cell populations with non-cycling S phase cells. J Theor Biol 1991;150:201-214.
21. Terry NH, Meistrich ML, Roubein LD, Lynch PM, Dubrow RA, Rich TA. Cellular kinetics in rectal cancer. Br J Cancer 1995;72:435-441.
22. Begg AC, Haustermans K, Hart AA, et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol 1999;50:13-23.
23. Gasinska A, Urbanski K, Jakubowicz J, Klimek M, Biesaga B, Wilson GD. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy. Radiother Oncol 1999;50:77-84.
24. Corvo R, Paoli G, Giaretti W, et al. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2000;47:57-63.
25. Wilson GD. A new look at proliferation. Acta Oncol 2001;40:989-994.
26. Cutress RI, Mullee MA, Rew DA. Clinical outcome and bromodeoxyuridine derived proliferation indices in 100 colonic and rectal carcinomas. Eur J Surg Oncol 2002;28:516-519.
27. Dobrowsky W, Dobrowsky E, Wilson GD. In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;55:576-582.
28. Wilson GD. Proliferation models in tumours. Int J Radiat Biol 2003; 79:525-530.
29. Wilson GD. Radiation and the cell cycle, revisited. Cancer Metastasis Rev 2004;23:209-225.
30. Asmuth DM, Wang N, Lu Y, et al. Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes. Cytometry 2005;66.
31. Steel GG. Cell loss as a factor in the growth rate of human tumours. Eur J Cancer 1967;3:381-387.
32. Bertuzzi A, Del GN, Gandolfi A, Sinisgalli C, Starace G. Cell cycle analysis by the relative movement approach: effect of variability across S-phase of DNA synthesis rate. Cell Prolif 1995;28:107-120.
33. Bertuzzi A, Gandolfi A, Sinisgalli C, Starace G, Ubezio P. Cell loss and the concept of potential doubling time. Cytometry 1997;29:34-40.
34. Bertuzzi A, Gandolfi A, Sinisgalli C, Iacoviello D. Steel's potential doubling time and its estimation in cell populations affected by nonuniform cell loss. Math Biosci 1997;143:61-89.
35. Schmidt W. Comment on R.A. White's v function. Cytometry 1996;24: 289-291.
36. Press WH. Numerical recipes in FORTRAN-the art of scientific computing. 2nd ed. Cambridge: Cambridge University Press: 1992.
37. Trucco E, Brockwell PJ. Percentage labeled mitoses curves in exponentially growing cell populations. J Theor Biol 1968;20:321-337.